How to Use Cholestyramine for Diarrhea
Start cholestyramine at a low dose of 2-4 g once daily and gradually titrate upward based on clinical response, with a maximum of 24 g/day, to treat bile acid malabsorption-related diarrhea. 1
Initial Dosing Strategy
Gradual dose titration is essential to minimize side effects 1. The 2020 Canadian Association of Gastroenterology guidelines designate this as a good practice statement based on the high frequency of gastrointestinal side effects and intolerance with bile acid sequestrant therapy (BAST).
- Starting dose: 2-4 g/day (one 4-g packet daily per FDA labeling) 1, 2
- For patients with pre-existing constipation: Start with 1 packet once daily for 5-7 days before increasing 2
- Titration schedule: Increase by one dose per day at monthly intervals based on response 1
- Maximum dose: 24 g/day 1, 2
Administration Instructions
Mix each 9-gram dose in at least 2-6 ounces of fluid before taking 2. Key administration points include:
- Take other medications at least 1 hour before or 4-6 hours after cholestyramine to avoid drug interactions 1, 2
- Do not hold the suspension in the mouth for prolonged periods (risk of tooth enamel erosion) 2
- Encourage increased fluid and fiber intake to prevent constipation 2
Expected Response and Effectiveness
Cholestyramine is effective in approximately 70% of patients with bile acid diarrhea 1. Response rates vary by severity:
- 67% in patients with SeHCAT retention <5%
- 73% in those with SeHCAT retention <8-11.7%
- 59% in those with SeHCAT retention <15% 1
Clinical improvement typically occurs rapidly when effective 3, 4.
Common Side Effects and Tolerability Issues
Approximately 11% of patients find cholestyramine intolerable due to unpalatability or side effects 1. The most common adverse effects include:
- Abdominal bloating and pain
- Constipation (manage with stool softeners if needed) 2
- Dyspepsia, nausea/vomiting
- Flatulence and borborygmi
- Paradoxical worsening of diarrhea 1
If cholestyramine is not tolerated, switch to colesevelam as second-line therapy 1. Colesevelam has similar efficacy (73% response rate) but better tolerability, with side effect rates similar to placebo 1.
Maintenance Therapy
Once symptoms are controlled, use the lowest effective dose and attempt intermittent, on-demand dosing 1. This approach:
- Minimizes exposure to potential long-term harms (fat-soluble vitamin malabsorption)
- Improves compliance
- Reduces costs
Studies show that 61% of patients can maintain symptom control with on-demand therapy after initial treatment 1, though 94% may experience recurrence if therapy is completely withdrawn 1.
Critical Contraindication
Avoid cholestyramine in patients with Crohn's disease with extensive ileal involvement or resection >100 cm 1. In these patients, BAST can paradoxically increase steatorrhea and cause substantial caloric loss despite reducing diarrhea frequency 1.
Drug Interactions - Essential Review
Review all concurrent medications before starting cholestyramine 1. Cholestyramine binds numerous drugs, reducing their absorption, including:
- Thyroid preparations and levothyroxine
- Warfarin
- Thiazide diuretics, furosemide
- Digoxin
- Oral contraceptives
- Phenobarbital, phenytoin
- Tetracycline, penicillin G 1, 2
Monitoring Considerations
While the guidelines could not make a firm recommendation regarding routine vitamin monitoring 1, consider:
- Fat-soluble vitamin supplementation (A, D, E, K) if deficiency occurs during long-term use 1, 2
- Vitamin K monitoring in patients on warfarin or with bleeding risk
- Re-evaluation if symptoms worsen or persist despite stable dosing 1
Alternative Therapy if BAST Fails
If cholestyramine and other bile acid sequestrants are not tolerated, use loperamide or other antidiarrheal agents 1. While evidence is limited, loperamide has shown benefit in some patients with bile acid diarrhea, particularly those without extensive ileal resection 1.